Expanded (Regional) Pilot and Feasibility Program
Expanded (Regional) Pilot and Feasibility Program
批准号:
10585210
负责人:
Scott Soleimanpour
金额:
$23.27万
依托单位国家:
美国
项目类别:
财政年份:
1996
资助国家:
美国
项目状态:
未结题
起止时间:
1996-12-01 至 2027-11-30
关键词:
AccelerationAgreementApplications GrantsAreaAwardBiomedical ResearchClinical ResearchCollaborationsCommunicationCost SharingDataDiabetes MellitusEligibility DeterminationEndocrine System DiseasesExpenditureExtramural ActivitiesFacultyFundingGoalsGrantInstitutionInstructionMetabolic DiseasesMichiganMonitorNational Institute of Diabetes and Digestive and Kidney DiseasesOhioPaperPeer ReviewProcessProgress ReportsPublicationsPublishingRecording of previous eventsReportingResearchResearch PersonnelResearch SupportResourcesScienceUnited States National Institutes of HealthUniversitiescareerinnovationinterdisciplinary collaborationinterestpreventprogramsrecruitresearch facultysuccess
中文摘要
项目摘要/摘要-扩大(区域)试点和可行性赠款计划
密歇根糖尿病研究中心(MDRC)扩大(区域)试点的具体目标/可行性
(P/F)赠款计划旨在促进糖尿病及其并发症领域的新研究和合作
以及相关的内分泌和代谢紊乱。这项研究可能是在基础领域
生物医学或临床研究。该计划将为调查人员提交的至少3个P/F补助金提供资金
每年从我们的五个地区合作伙伴那里。MDRC每年将提供至少150,000美元,并将提供
每年至少额外提供20,000美元,通过与
托莱多大学、密歇根州立大学、韦恩州立大学、俄亥俄州立大学和凡
安德尔研究所。每年,该中心都会向全日制教学或研究人员征集拨款申请。
这五个机构的教职员工。符合条件的人包括:1)没有现任或前任NIH的新调查人员
开始从事糖尿病研究的研究支持人员,2)建立了糖尿病新手的研究人员
希望将他们的专业知识集中在糖尿病上的研究,以及3)提出
糖尿病方面的创新研究,与他们正在进行的研究明显背道而驰。应用程序是
由至少两名在申请领域具有专业知识的外部调查人员进行同行审查。那些拥有
优点,根据这一审查过程和赠款方案咨询委员会的判断,该委员会包括
来自五个区域伙伴机构的代表将获得P/F奖。这笔赠款的最终目标
该计划旨在加强区域糖尿病研究人员之间的沟通和合作,加快
研究速度,并使获奖者能够生成足够的初步数据,以成功申请
来自美国国立卫生研究院或其他国家拨款机构的主要研究经费。
英文摘要
Project Summary/Abstract – Expanded (Regional) Pilot and Feasibility Grants Program
The specific aim of the Michigan Diabetes Research Center (MDRC) Expanded (Regional) Pilot/Feasibility
(P/F) Grants Program is to stimulate new research and collaboration in the areas of diabetes, its complications
and related endocrine and metabolic disorders in the region. This research may be in areas of basic
biomedical science or clinical research. This program will fund at least 3 P/F grants submitted by investigators
from our five regional partners per year. A minimum of $150,000 per year will be provided by the MDRC and a
minimum of an additional $20,000 per year will be provided through cost-sharing agreements with the
University of Toledo, Michigan State University, Wayne State University, The Ohio State University and Van
Andel Institute. Each year, the MDRC will solicit applications for grants from full-time instructional or research
faculty at these five institutions. Those eligible include: 1) new investigators without current or past NIH
research support who are beginning careers in diabetes research, 2) established investigators new to diabetes
research who wish to focus their expertise on diabetes, and 3) established investigators who propose
innovative research in diabetes that represents a clear departure from their ongoing research. Applications are
peer-reviewed by at least two extramural investigators with expertise in the area of the application. Those with
merit, as judged by this review process and the Grants Program Advisory Council, which includes
representatives from the five regional partner institutes, will receive P/F awards. The ultimate goal of the grant
program is to enhance communication and collaboration among regional diabetes researchers, accelerate the
pace of research, and enable awardees to generate sufficient preliminary data for successful applications for
major research funding from the NIH or other national granting agencies.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Type 2 diabetes risk variant effects on mitochondrial (patho)physiology
-
批准号:10717519
-
项目类别:
-
资助金额:$78.88万
-
财政年份:2023
-
负责人:Scott Soleimanpour
-
依托单位:
Control of beta cell identity by the mitochondrial life cycle
-
批准号:10619610
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2020
-
负责人:Scott Soleimanpour
-
依托单位:
Control of beta cell identity by the mitochondrial life cycle
-
批准号:9890737
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2020
-
负责人:Scott Soleimanpour
-
依托单位:
Control of beta cell identity by the mitochondrial life cycle
-
批准号:10454761
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2020
-
负责人:Scott Soleimanpour
-
依托单位:
Mediators of mitophagy in the regulation of beta cell function
-
批准号:9237051
-
项目类别:
-
资助金额:$38.75万
-
财政年份:2016
-
负责人:Scott Soleimanpour
-
依托单位:
Mediators of mitophagy in the regulation of beta cell function
-
批准号:9761533
-
项目类别:
-
资助金额:$38.75万
-
财政年份:2016
-
负责人:Scott Soleimanpour
-
依托单位:
Endosomal regulation of GLP-1 receptor function in beta cells by Clec16a
-
批准号:9086362
-
项目类别:
-
资助金额:$7.75万
-
财政年份:2015
-
负责人:Scott Soleimanpour
-
依托单位:
Endosomal regulation of GLP-1 receptor function in beta cells by Clec16a
-
批准号:8949507
-
项目类别:
-
资助金额:$7.75万
-
财政年份:2015
-
负责人:Scott Soleimanpour
-
依托单位:
The Role of Clec16a in the Pancreatic Islet
-
批准号:8394578
-
项目类别:
-
资助金额:$15.51万
-
财政年份:2012
-
负责人:Scott Soleimanpour
-
依托单位:
The Role of Clec16a in the Pancreatic Islet
-
批准号:8242336
-
项目类别:
-
资助金额:$15.51万
-
财政年份:2012
-
负责人:Scott Soleimanpour
-
依托单位:
The Role of Clec16a in the Pancreatic Islet
-
批准号:8984302
-
项目类别:
-
资助金额:$15.51万
-
财政年份:2012
-
负责人:Scott Soleimanpour
-
依托单位:
The Role of Clec16a in the Pancreatic Islet
-
批准号:8594240
-
项目类别:
-
资助金额:$15.51万
-
财政年份:2012
-
负责人:Scott Soleimanpour
-
依托单位:
Pilot and Feasibility Program
-
批准号:10585209
-
项目类别:
-
资助金额:$39.71万
-
财政年份:1996
-
负责人:Scott Soleimanpour
-
依托单位:
海外基金